What Is Cartalax Peptide?
Cartalax is a tripeptide, three amino acids long, with the sequence Ala-Glu-Asp, often written AED. It is one of the short peptide bioregulators developed by Professor Vladimir Khavinson and colleagues at the St Petersburg Institute of Bioregulation and Gerontology, a research programme built on the idea that very short peptides can influence gene expression in specific tissues. Each bioregulator in the family is associated with a tissue, and Cartalax, as its name suggests, is the cartilage peptide.
There is a neat link to another peptide we stock. Cartalax's sequence, Ala-Glu-Asp, is the first three amino acids of epitalon, Ala-Glu-Asp-Gly. The two come from the same research programme and differ by a single glycine, yet they are studied for different tissues: epitalon for the pineal gland, Cartalax for cartilage and connective tissue.
Cartalax Bioregulator: What Does Cartalax Do?
Research on Cartalax comes almost entirely from Khavinson's group and collaborators, and it is mainly in cultured cells. Studies examine how the AED peptide affects the expression of genes and proteins linked to cell ageing and to the maintenance of connective tissue, including in cultures of cells from cartilage and skin. The underlying hypothesis of the bioregulator programme is that short peptides like Cartalax can interact with DNA and chromatin to switch tissue-specific genes on or off.
That hypothesis is still being tested, and independent replication outside the originating group is limited. For researchers, that makes Cartalax a compound to study rather than one with settled answers, and a defined, lot-tested supply matters more for that reason, not less.
Cartalax vs BPC-157 and Sigumir
| Cartalax | BPC-157 | |
|---|---|---|
| Length | 3 amino acids (Ala-Glu-Asp) | 15 amino acids |
| Origin | Khavinson peptide bioregulator programme | Fragment of a protein in human gastric juice |
| Proposed mechanism | Influence on tissue-specific gene expression | Growth factor and nitric oxide signalling |
| Main research | Cartilage and connective tissue, cell ageing | Tendon, gut and soft tissue repair |
| Research base | Mostly one research group | Several decades, several groups |
| Chainwell vial | 20mg | 10mg, or capsules |
Cartalax and BPC-157 both come up in searches about connective tissue, but they are unrelated compounds with different mechanisms and a very different depth of published research. Sigumir is a separate product from the same bioregulator tradition, sold as a supplement-style preparation for cartilage and bone; it is not the defined synthetic tripeptide that Cartalax is. For tissue repair research with a broader literature, see our tissue repair research peptides.
Cartalax 20mg Vial
Chainwell Peptide supplies Cartalax as a 20mg lyophilized vial, a 3 mL clear glass vial with a rubber stopper and teal flip-off cap, the colour we use across our sleep and longevity research peptides. At about 333 g/mol, 20mg of Cartalax is roughly 60 micromoles of peptide.
To reconstitute Cartalax, add bacteriostatic water slowly down the inside wall with a U-100 insulin syringe and swirl gently until clear; do not shake. As a worked example, 2 mL in the 20mg vial gives 10mg per mL. Keep the reconstituted vial at 2 to 8 °C, protected from light, and use it within 28 days; unopened, it keeps longest frozen at minus 20 °C. Our reconstitution guide and calculator covers other volumes.
Cartalax Capsules and Oral Forms
Khavinson's bioregulators are sold in some markets as capsules and sublingual products, which is where searches for Cartalax capsules and oral Cartalax come from. We supply Cartalax as a lyophilized vial only: it gives you the defined synthetic peptide, verified by lot, to prepare at the concentration and in the vehicle your study design calls for. Published data on Cartalax's half-life and oral uptake are limited.
Lab-Tested Cartalax With a COA for Every Lot
With a peptide this short, identity testing does real work: Ala-Glu-Asp differs from related sequences by a single amino acid. Every Chainwell Peptide Cartalax lot is sent to an independent laboratory before release, where mass spectrometry confirms the molecular mass matches Cartalax and HPLC measures purity. A lot that does not meet specification is not sold. Check the Cartalax COA for your lot on our COA lookup page, and see our guide on how to read a certificate of analysis.
Buy Cartalax in Australia
Chainwell Peptide supplies Cartalax peptide for sale in Australia to laboratories, universities and independent researchers, packed and dispatched from within Australia. Before you buy Cartalax from any supplier, check that the listing gives the sequence and fill, and that a lot-matched certificate is available before you pay.
- Same-day dispatch on orders paid before 3pm on a business day.
- Australia-wide delivery to Sydney, Melbourne, Brisbane, Adelaide, Perth, Hobart, Darwin and regional addresses, by standard or express post.
- PayID or bank transfer, with your order number as the payment reference.
- Tracked orders you can follow on our order tracking page.
The current price is shown at the top of this page, with GST included. See our shipping policy for delivery details.
Cartalax Specifications
| Compound | Cartalax |
|---|---|
| Class | Synthetic tripeptide, peptide bioregulator |
| Sequence | Ala-Glu-Asp (AED) |
| Molecular formula | C12H19N3O8 |
| Molecular weight | Approximately 333.3 g/mol |
| Fill | 20mg per vial |
| Form | Lyophilized (freeze-dried) powder |
| Container | 3 mL clear glass vial, rubber stopper, teal flip-off cap |
| Identity and purity | Mass spectrometry and HPLC, per lot |
| Diluent | Bacteriostatic water, sold separately |
| Storage | Minus 20 °C long term, 2 to 8 °C once reconstituted, protect from light |
| Shipping | Standard or express post, Australia-wide |
Research Use Only
Cartalax is not approved by the Therapeutic Goods Administration for any therapeutic use. Chainwell Peptide sells it strictly for laboratory and in vitro research. It is not for human or veterinary use, and we do not provide dosing advice. By ordering you agree to our terms and conditions and research use only statement.
Cartalax FAQ
What is Cartalax peptide?
+
Cartalax is a synthetic tripeptide, Ala-Glu-Asp, from the family of short peptide bioregulators developed by Vladimir Khavinson in St Petersburg. It is the member of that family associated with cartilage and connective tissue research. Chainwell Peptide supplies it as a 20mg lyophilized research vial.
What does Cartalax do?
+
In research, Cartalax is studied for effects on the expression of genes and proteins linked to connective tissue and cell ageing, mainly in cultured cells. Most studies come from one research group, and the bioregulator hypothesis behind it is still being tested.
How is Cartalax related to epitalon?
+
Cartalax, Ala-Glu-Asp, is the first three amino acids of epitalon, Ala-Glu-Asp-Gly. Both come from the Khavinson bioregulator programme and differ by one glycine, but they are studied for different tissues: epitalon for the pineal gland, Cartalax for cartilage.
Is Cartalax the same as BPC-157?
+
No. Cartalax is a three amino acid bioregulator proposed to act on tissue-specific gene expression. BPC-157 is a 15 amino acid fragment of a gastric protein with a much larger research base in tendon and gut repair. They are unrelated compounds.
How do you reconstitute Cartalax 20mg?
+
Add bacteriostatic water slowly down the inside wall of the vial and swirl gently until clear, without shaking. 2 mL in the 20mg vial gives 10mg per mL. Store the reconstituted vial at 2 to 8 °C, protected from light, and use it within 28 days.
Where can I buy Cartalax in Australia?
+
You can buy Cartalax in Australia from Chainwell Peptide as a 20mg lyophilized vial. Every lot carries a lot number matched to an independent certificate of analysis, and orders paid before 3pm on a business day ship the same day by standard or express post.






